MASI: Masimo Corp Long-Term Debt Volume

Graphic logo of Masimo Inc. (MASI)

The trajectory of Masimo Corporation (MASI) long-term debt confirms the company's financial stability. Multi-year agreements with clinics ensure a steady cash flow, while the 0.45 mark indicates the current state of indebtedness. Revenues are based on the sale of advanced pulse oximeters and consumables. High free cash flow is guaranteed through the sale of high-margin sensors for the primary monitoring systems.

MASI Masimo Corporation: Company Long-Term Debts in the range 07/04/2022 - 06/21/2026

Analytical breakdowns for Masimo Corporation

- price and consensus price forecast:
Share Price masimo.com|MASI - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Masimo|MASI - Enterprise Value
- book capitalization data:
Accounting Value per Share Masimo|MASI - Book Capitalization|Market Capitalization to Book Value Ratio masimo.com|MASI - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Masimo Corporation|MASI - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Masimo Inc.|MASI - Company Aggregate Debts|Debts to Net Assets Masimo|MASI - Company Long-Term Debt|Company Short-Term Indebtedness Masimo
General company analysis:masimo.com (MASI)
Mass-produced product of Masimo Inc.

This metric accumulates obligations with maturities exceeding one year, reflecting the total volume of borrowed capital that impacts the financial stability of Masimo Corporation (MASI) at the current value of 0.45. Analyzing changes in the organization's long-term financial debt allows for an assessment of how effectively the company finances the development of non-invasive medical technologies without creating a critical debt burden on its budget.

Competitor analysis

Company Long-Term Indebtedness intuitive.com ISRG|Company Long-Term Debts DHR (Danaher)|BDX - Long-Term Debt Volume|STE (STERIS Corporation) - Company Long-Term Debts|West Pharma Corp (WST) - Company Long-Term Liabilities|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts STVN|Company Long-Term Debt Teleflex (TFX)|Company Long-Term Debt Merit Medical Systems, Inc. MMSI|Company Long-Term Liabilities Envista Holdings Corp|Company Long-Term Loans and Borrowings ICU Medical Inc. ICUI|Company Long-Term Debts XRAY (DENTSPLY SIRONA Inc.)|LMAT: Long-Term Debt Volume|Company Long-Term Debt AtriCure|STAA (STAAR Surgical Co.) - Company Long-Term Indebtedness|NAGE: Company Long-Term Debt|Long-Term Debt Volume ZimVie Corp (ZIMV)|Company Long-Term Liabilities AngioDynamics, Inc.|Amount of Long-Term Liabilities CERS (cerus.com)|Company Long-Term Debt Teknova|MGRM - Company Long-Term Loans and Borrowings|Sharps Tech - Company Long-Term Liabilities|INFU: Company Long-Term Debts|UTMD (Utah Medical Products) - Company Long-Term Debt|KORU Medical (KRMD) - Company Long-Term Liabilities|Company Long-Term Debts NYXH (Nyxoah)|Long-Term Debt MBOT|Company Long-Term Debt Pro-Dex Corp PDEX|Company Long-Term Indebtedness Zentek Corp ZTEK|Company Long-Term Liabilities Elutia Inc. (ELUT)|milestonescientific.com - Amount of Long-Term Liabilities|Company Long-Term Debt NXGL (NEXGEL)|RVP: Long-Term Debt Volume|HBIO (Harvard Bioscience, Inc.) - Company Long-Term Debt|Femasys Corporation (FEMY) - Company Long-Term Liabilities|MHUA (Meihua Medical Technologies) - Company Long-Term Debts|Company Long-Term Debts POAI|CJMB (Callan JMB Inc) - Company Long-Term Debt|Long-Term Debt Volume Atrion Corp. (ATRI)|Company Long-Term Debts NURO